Clinical Trials Browser

Withdrawn × Prostatic Neoplasms × radium Ra 223 dichloride × Clear all

NCT05771896 2023-09-14

CARE

Phase 3 Withdrawn

Prostatic Neoplasms

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT02396368 2015-11-20

Radium-223

Phase 1 Withdrawn

Prostatic Neoplasms